ArticleLung cancer (Amsterdam, Netherlands)2019

Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis.

Mark M Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.